840 Results for "

cleavable ADC linker

" in MedChemExpress (MCE) Product Catalog:
Products (840)

840 Results for "cleavable ADC linker" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-136170
CAS No.: 1473403-87-0
Purity:  98.94%
Research Areas:  

Cancer

MC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC). SN-38, an active metabolite of the Topoisomerase I inhibitor Irinotecan, inhibits DNA synthesis and causes frequent DNA single-strand breaks .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116063
CAS No.: 400647-59-8
Purity:  98.80%
Research Areas:  

Cancer

Doxorubicin-SMCC is a agent-linker conjugate for ADC. Doxorubicin-SMCC contains a non-cleavable ADC linker and a DNA topoisomerase II inhibitor Doxorubicin .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101153
CAS No.: 1342211-31-7
Purity:  99.79%
Target:  

ADC Linkers

Research Areas:  

Cancer

MC-Val-Ala-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-140118
CAS No.: 864235-83-6
Purity:  99.53%
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114430
CAS No.: 1646299-50-4
Purity:  98.15%
Target:  

ADC Linkers

Research Areas:  

Others

Fmoc-Phe-Lys(Boc)-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-129368
CAS No.: 890409-85-5
Purity:  96.37%
Target:  

ADC Linkers

Research Areas:  

Cancer

SPDMV is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W040236
CAS No.: 869718-81-0
Research Areas:  

Cancer

m-PEG8-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-140145
CAS No.: 2112738-09-5
Purity:  96.19%
Target:  

ADC Linkers

Research Areas:  

Cancer

Mal-PEG4-Val-Cit-PAB-PNP is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141154
CAS No.: 1492056-71-9
Purity:  99.93%
Research Areas:  

Cancer

Amino-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120237
CAS No.: 170572-38-0
Purity:  ≥97.0%
Research Areas:  

Cancer

m-PEG7-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130408
CAS No.: 184357-46-8
Purity:  ≥97.0%
Research Areas:  

Cancer

m-PEG6-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG6-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W018174
CAS No.: 74654-07-2
Research Areas:  

Cancer

m-PEG3-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG3-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W040214
CAS No.: 85030-56-4
Research Areas:  

Cancer

m-PEG4-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG4-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-147095
CAS No.: 2845164-91-0
Purity:  99.90%
Research Areas:  

Cancer

Val-Ala-PABC-Exatecan is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (HY-13631) (topoisomerase I inhibitor). Val-Ala-PABC-Exatecan can be used for ADC molecues synthesis, such as Mal-PEGn-amide-va-Exatecan .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-147095A
CAS No.: 2928571-45-1
Purity:  98.39%
Research Areas:  

Cancer

Val-Ala-PABC-Exatecan trifluoroacetate is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor, HY-13631). Val-Ala-PABC-Exatecan trifluoroacetate can be used for ADC molecues synthesis, such as Mal-PEGn-amide-va-Exatecan .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-131056
CAS No.: 2684216-48-4
Purity:  99.63%
Research Areas:  

Cancer

Gly3-VC-PAB-MMAE consists a cleavable ADC linker (Gly3-VC-PAB) and a potent tubulin inhibitor (MMAE). Gly3-VC-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133429
CAS No.: 2748394-67-2
Purity:  98.05%
Target:  

ADC Linkers

Research Areas:  

Cancer

DBCO-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-oxyamine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-140139
CAS No.: 1802907-98-7
Purity:  ≥95.0%
Target:  

ADC Linkers

Research Areas:  

Cancer

PC Alkyne-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Alkyne-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99542
CAS No.: 2254086-60-5
Synonyms: SAR-408701; HuMAb2-3-SPDB-DM4
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141155
CAS No.: 2762519-08-2
Purity:  99.95%
Research Areas:  

Cancer

endo-BCN-PEG4-Val-Cit-PAB-MMAE is a cleavable ADC linker conjugated with drug containing 4-unit PEG, which can be used for synthesizing antibody-drug conjugates (ADCs). endo-BCN-PEG4-Val-Cit-PAB-MMAE is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups .
loading...
    loading...